Want to see EDIT full AI Analyst Report?
Editas Medicine (EDIT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Edit-301 | Hemoglobinopathies, Thalassemia Major, Transfusion Dependent Beta Thalassemia, Thalassemia Intermedia | phase1AndPhase2 | Active Not Recruiting | EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) | Jun 27, 2022 | ― |
| Edit-301 | Sickle Cell Disease, Hemoglobinopathies | phase1AndPhase2 | Active Not Recruiting | A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) | Apr 16, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Edit-301 | phase1AndPhase2 | Hemoglobinopathies, Thalassemia Major, Transfusion Dependent Beta Thalassemia, Thalassemia Intermedia | Active Not Recruiting | EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) | Jun 27, 2022 | ― |
| Edit-301 | phase1AndPhase2 | Sickle Cell Disease, Hemoglobinopathies | Active Not Recruiting | A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) | Apr 16, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Editas Medicine Inc. (EDIT) have in its pipeline
Editas Medicine EDIT is currently developing the following drugs: Edit-301. These drug candidates are in various stages of clinical development as the company works toward FDA approval.